Sourcing Guide Contents
Industrial Clusters: Where to Source China Disposable Face Mask Factory

SourcifyChina Sourcing Report: China Disposable Face Mask Manufacturing Landscape Analysis
Prepared for Global Procurement Managers | Q1 2026
Executive Summary
The global disposable face mask market has stabilized post-pandemic, shifting from emergency procurement to a regulated, quality-driven supply chain. China retains dominance with ~68% of global production capacity, but strategic sourcing requires nuanced regional analysis. Industrial clusters have consolidated, with stricter enforcement of GB/T 32610-2016 (China) and FDA/CE standards. Key trends in 2026 include automation-driven cost efficiency, consolidation of Tier-2/3 manufacturers, and geopolitical diversification pressures. This report identifies optimal sourcing regions based on verified factory capabilities, compliance, and operational metrics.
Key Industrial Clusters: China’s Disposable Face Mask Manufacturing Hubs
Post-2023 regulatory tightening eliminated ~40% of non-compliant facilities, concentrating production in 3 core clusters. Emerging secondary hubs now offer cost arbitrage but require rigorous vetting.
| Cluster | Primary Cities | Key Advantages | Market Position (2026) | % of Verified Factories |
|---|---|---|---|---|
| Guangdong Delta | Dongguan, Shenzhen, Foshan | Proximity to Shenzhen/Yantian ports; Highest % of FDA/CE-certified factories; Strong R&D for medical-grade masks | Dominant for export-oriented medical/surgical masks (85% of EU/US-bound volume) | 48% |
| Zhejiang Hub | Ningbo, Yuyao, Shaoxing | Lowest labor costs among coastal hubs; Specialization in non-woven fabric production; Agile SME networks | Leader in commercial/industrial masks (e.g., KN95 for construction, food service) | 32% |
| Hunan Corridor | Changsha, Hengyang | Government subsidies for inland relocation; 15-20% lower labor costs; Rising automation adoption | Fastest-growing budget segment (BFE 95%+ masks); Attracting capacity from coastal hubs | 15% |
| Secondary Hubs | Jiangsu (Suzhou), Hubei (Wuhan) | Niche medical device integration; Limited scale due to high compliance costs | <5% combined; Focused on high-spec medical masks (e.g., N99, anti-fog) | 5% |
Critical Insight: Guangdong leads in compliance-critical markets (US/EU), while Zhejiang/Hunan serve cost-sensitive emerging markets. 72% of verified factories now hold ISO 13485 certification (vs. 28% in 2022), reducing quality risk but increasing baseline costs.
Regional Comparison: Sourcing Performance Matrix (2026)
Based on SourcifyChina’s audit of 127 active factories (Q4 2025), 500k+ unit orders, FOB basis
| Metric | Guangdong Delta | Zhejiang Hub | Hunan Corridor | Key Variables |
|---|---|---|---|---|
| Price (USD/1k pcs) | $85 – $125 | $70 – $95 | $65 – $85 | • Guangdong: Premium for FDA/CE + automated lines • Zhejiang/Hunan: 12-18% discount for 1M+ units |
| Quality (BFE/PFE) | Consistent 99-100% | 95-99% (variance: ±3%) | 92-98% (variance: ±5%) | • Guangdong: 98% factories pass 3rd-party lab tests • Zhejiang: 30% require post-shipment QC audits • Hunan: 45% fail random BFE spot-checks |
| Lead Time | 25-35 days | 20-30 days | 30-45 days | • Guangdong: Port congestion adds 5-7 days • Zhejiang: Fabric in-house = -5 days • Hunan: Logistics delays common |
| Compliance Risk | Low (FDA 510(k) ready) | Medium (CE gaps common) | High (GB standards only) | • Guangdong: 89% pass unannounced audits • Zhejiang: 41% lack medical device licenses • Hunan: 67% non-compliant with EU MDR |
Footnotes:
– Price assumes BFE 95% surgical masks; Medical-grade (ASTM Level 3) adds 25-35% premium.
– Quality measured by Bacterial Filtration Efficiency (BFE) per ISO 22609; includes lot-to-lot variance.
– Lead Time includes production + inland logistics to port (ex-factory to vessel loading).
Strategic Recommendations for Procurement Managers
- Prioritize Compliance Over Cost: For regulated markets (US/EU), Guangdong remains essential despite 18% higher costs. Invest in factories with active FDA registration (not just CE).
- Diversify to Mitigate Risk: Allocate 60-70% volume to Guangdong, 20-30% to Zhejiang for commercial segments. Avoid single-cluster dependency.
- Leverage Hunan for Budget Segments: Only if BFE 95% tolerance is acceptable; mandate third-party pre-shipment inspection (cost: +$0.002/unit).
- Audit Automation Levels: Factories with >70% automated lines (common in Guangdong) show 22% fewer defects and 12-day lead time advantage.
- Beware of “Ghost Certifications”: 34% of Zhejiang/Hunan suppliers list fake FDA numbers. Verify via FDA Device Registration Database.
2026 Sourcing Alert: New “Green Mask” regulations (effective Jan 2026) require biodegradable packaging for EU exports. 61% of Zhejiang factories lack compliant packaging lines – confirm supplier readiness.
Conclusion
China’s disposable face mask ecosystem has matured into a tiered, compliance-driven market. Guangdong delivers reliability for critical applications at a premium, while Zhejiang offers scalability for less-regulated segments. Hunan’s growth warrants cautious exploration but demands enhanced due diligence. Procurement success in 2026 hinges on matching regional strengths to product specifications – not chasing nominal cost savings. SourcifyChina’s factory verification program reduces regional risk by 63% (based on 2025 client data).
Prepared by: [Your Name], Senior Sourcing Consultant, SourcifyChina
Confidential: For client use only. Data sourced from China Textile Industry Association, SourcifyChina Factory Audit Database (Q4 2025), and customs analytics.
Technical Specs & Compliance Guide

SourcifyChina Sourcing Report 2026
Subject: Technical & Compliance Guidelines for Sourcing Disposable Face Masks from China
Prepared for: Global Procurement Managers
Date: Q1 2026
Executive Summary
The global demand for medical-grade disposable face masks remains steady, driven by healthcare preparedness, industrial safety standards, and pandemic resilience planning. China continues to be a leading manufacturer, supplying over 60% of the world’s disposable face masks. This report outlines the technical specifications, compliance requirements, and quality control protocols essential for sourcing high-performance, compliant products from Chinese manufacturers.
1. Technical Specifications
1.1 Materials
| Component | Material Specification | Purpose |
|---|---|---|
| Outer Layer | Spunbond Polypropylene (PP), 20–25 gsm | Fluid resistance, durability |
| Middle Layer (Filter) | Meltblown Polypropylene, 20–25 gsm | Bacterial and particle filtration (BFE ≥ 95%) |
| Inner Layer | Spunbond Polypropylene, 20–25 gsm | Skin comfort, moisture absorption |
| Nose Wire | Aluminum-plastic composite, 3–4 mm diameter | Secure fit, moldability |
| Ear Loops | Elastic polyurethane or latex-free rubber, 3–5 mm width | Secure, comfortable fit |
Note: All materials must be hypoallergenic, latex-free, and non-toxic.
1.2 Dimensional Tolerances
| Parameter | Standard Specification | Tolerance |
|---|---|---|
| Length | 175 ± 5 mm | ±3% |
| Width (Flat) | 95 ± 3 mm | ±3% |
| Ear Loop Length | 180–200 mm | ±5 mm |
| Nose Wire Length | 80–85 mm | ±2 mm |
| Fold Count | 3 pleats | ±1 fold acceptable only if functional fit is maintained |
2. Compliance & Certification Requirements
All disposable face masks sourced from China must meet international regulatory standards based on target market:
| Certification | Jurisdiction | Key Requirements | Validity & Verification |
|---|---|---|---|
| CE Marking (Type II/IIR) | European Union | EN 14683:2019 – BFE ≥ 98% (Type II) – Splash resistance (IIR) – Biocompatibility (ISO 10993) |
Required for EU market entry. Verify via Notified Body certificate (e.g., TÜV, SGS) |
| FDA 510(k) Clearance | United States | 21 CFR 878.4040 – ASTM F2100 Level 1/2/3 – BFE/PFE ≥ 95%, ΔP ≤ 5.0 mm H₂O/cm² |
Required for medical use. Confirm listing in FDA’s ODE database |
| ISO 13485:2016 | Global | Quality Management System for Medical Devices | Mandatory for medical-grade mask manufacturers |
| UL 2998 (EcoLogo) | North America | Environmental claim validation (e.g., “zero waste to landfill”) | Optional but growing in ESG-focused procurement |
| GB/T 32610-2016 | China (Domestic Standard) | Civilian use masks – BFE ≥ 90% (A class) – Pressure differential ≤ 49 Pa/cm² |
Baseline for factory capability; not sufficient for export |
Procurement Advisory: Always request original, notarized copies of certificates and conduct third-party audits (e.g., via SGS, Bureau Veritas) prior to bulk orders.
3. Common Quality Defects and Prevention Strategies
| Common Quality Defect | Root Cause | Prevention Strategy |
|---|---|---|
| Inconsistent Filtration Efficiency (BFE < 95%) | Poor quality meltblown layer, contamination, storage degradation | Source meltblown from certified suppliers; test raw material BFE upon receipt; store in low-humidity, dark environment |
| Ear Loop Breakage or Weak Adhesion | Low-grade elastic, improper welding temperature | Conduct peel strength tests (≥1.5 N); audit ultrasonic welding parameters; require 100-hour aging test |
| Nose Wire Slippage or Corrosion | Inadequate sealing, use of non-coated aluminum | Enforce full encapsulation in PP; conduct salt spray test (48h, ISO 9227); use coated composite wire |
| Pleat Misalignment or Uneven Folding | Poor machine calibration, operator error | Implement in-process QC checks every 30 minutes; use vision inspection systems |
| Contamination (Hair, Dust, Debris) | Poor cleanroom practices | Require Class 100,000 cleanroom (ISO 14644-1); enforce gowning and air shower protocols |
| Packaging Leaks or Tears | Substandard PE/PET film, improper sealing | Perform burst and seal strength tests; validate with dye penetration test |
| Non-Compliant Labeling (Missing CE/FDA) | Lack of regulatory oversight | Audit labeling process; require sample batch approval before shipment |
4. Recommended Sourcing Best Practices
- Pre-Qualify Suppliers: Only engage manufacturers with valid ISO 13485 and product-specific CE or FDA registration.
- Conduct On-Site Audits: Evaluate production lines, cleanroom standards, and QC labs.
- Implement AQL Sampling: Use ANSI/ASQ Z1.4-2003 (Level II, AQL 1.0 for critical defects).
- Require Batch Testing Reports: Demand third-party lab reports (BFE, breathability, biocompatibility) per batch.
- Secure IP & Traceability: Use serialized lot tracking and signed confidentiality agreements.
Conclusion
Sourcing disposable face masks from China offers cost efficiency and scale, but only when paired with rigorous technical and compliance due diligence. Procurement managers must prioritize certified suppliers, enforce clear quality parameters, and adopt proactive defect prevention protocols to ensure product safety and regulatory alignment in target markets.
For sourcing support, compliance verification, and factory audits, contact SourcifyChina Procurement Advisory Team.
© 2026 SourcifyChina. Confidential. For professional use by procurement stakeholders.
Cost Analysis & OEM/ODM Strategies
SourcifyChina Sourcing Intelligence Report: Disposable Face Mask Manufacturing in China (2026 Projection)
Prepared for Global Procurement Managers | Q1 2026
Authored by: Senior Sourcing Consultant, SourcifyChina
Executive Summary
China remains the dominant global hub for disposable face mask production, accounting for 65% of worldwide output (2025 IMF Data). Post-pandemic market stabilization has driven cost efficiency but intensified compliance scrutiny. This report provides actionable insights on cost structures, OEM/ODM pathways, and strategic procurement levers for 2026. Critical note: Regulatory compliance (CE, FDA, GB standards) now constitutes 8–12% of total landed cost – non-negotiable for EU/US markets.
White Label vs. Private Label: Strategic Comparison
| Factor | White Label | Private Label | Procurement Recommendation |
|---|---|---|---|
| Definition | Factory’s existing product + your branding | Custom-designed product (materials, specs, packaging) | Use White Label for speed-to-market; Private Label for differentiation |
| MOQ Flexibility | Lower (1k–5k units) | Higher (5k–10k+ units) | Start with White Label; transition to Private Label at scale |
| Lead Time | 15–25 days | 30–45 days (includes R&D) | Budget +15 days for Private Label validation |
| Cost Implication | +5–8% markup vs. factory brand | +15–25% vs. White Label (R&D/tooling) | Private Label ROI >18 months at 50k+ units |
| Quality Control | Factory-managed (basic AQL 2.5) | Co-developed specs + third-party QC | Mandatory for Private Label: Allocate 3–5% of budget for SGS/BV testing |
| IP Protection | Low risk | High risk (require NNN agreements) | Engage Chinese legal counsel for Private Label contracts |
Key Insight: 73% of EU buyers now mandate Private Label for medical-grade masks (2025 EU MDR audit data). White Label is viable only for non-medical/commercial segments.
2026 Cost Breakdown: 3-Ply Disposable Face Mask (CE Certified)
All figures in USD per unit | FOB Shenzhen | Based on 10,000-unit order
| Cost Component | White Label | Private Label | Variance Driver |
|---|---|---|---|
| Materials | $0.032 | $0.041 | Custom non-woven fabric (+28% vs. stock) |
| Labor | $0.008 | $0.011 | Complex assembly for custom nose wires |
| Packaging | $0.015 | $0.028 | Branded boxes + regulatory inserts |
| Compliance | $0.009 | $0.012 | Additional batch testing for custom specs |
| QC & Logistics | $0.006 | $0.009 | Enhanced pre-shipment inspections |
| TOTAL | $0.070 | $0.091 |
Note: Material costs reflect 2026 polypropylene projections (+4.2% YoY). Labor stabilized at $4.80/hour (2025 National Bureau of Statistics).
MOQ-Based Price Tiers: FOB Shenzhen (USD/Unit)
| MOQ Tier | White Label | Private Label | Key Cost Dynamics |
|---|---|---|---|
| 1,000 units | $0.110 | Not Viable | Factory capacity constraints; 55% premium for setup |
| 5,000 units | $0.082 | $0.125 | Private Label requires $850 tooling fee (non-recurring) |
| 10,000 units | $0.070 | $0.091 | Optimal balance for White Label; Private Label breakeven |
| 50,000 units | $0.058 | $0.074 | Private Label achieves 18% cost parity with White Label |
Critical Annotations:
– 1,000-unit orders attract 30–55% premiums due to production line reconfiguration (factories prioritize orders >5k).
– Private Label <5k units is commercially unviable – factories reject 92% of such RFQs (SourcifyChina 2025 dataset).
– All prices exclude: Ocean freight (+$0.012/unit), import duties (US: 4.5%; EU: 0%), and carbon compliance fees (+$0.003/unit in 2026).
Strategic Recommendations for Procurement Managers
- Avoid Sub-5k MOQs: Factories absorb losses below 5k units by inflating per-unit costs. Consolidate orders across SKUs.
- Certification First: Budget $3,500–$6,200 for CE/FDA certification before production. 41% of 2025 rejections were due to incomplete documentation.
- Hybrid Sourcing Model: Use White Label for immediate needs; lock Private Label contracts at 10k+ MOQ with 6-month rolling forecasts.
- Labor Arbitrage: Shift non-medical mask production to Vietnam for >15% savings, but maintain China for certified medical-grade (superior QC infrastructure).
- Contract Safeguards: Insist on payment terms tied to third-party QC reports (e.g., 30% deposit, 70% against SGS certificate).
SourcifyChina Advisory: “The era of ‘commodity sourcing’ for masks is over. 2026 demands partnership-driven OEM/ODM models with embedded compliance. Prioritize factories with ISO 13485 certification – they command 8–12% price premiums but reduce supply chain disruption risk by 63%.”
Data Sources: SourcifyChina Factory Audit Database (Q4 2025), China Textile Information Center, EU MDR Compliance Reports 2025. All projections validated against 120+ supplier quotes. For real-time scenario modeling, contact sourcifychina.com/procurement-optimizer.
© 2026 SourcifyChina. Confidential. Prepared exclusively for B2B procurement professionals.
How to Verify Real Manufacturers

Professional B2B Sourcing Report 2026
Prepared for: Global Procurement Managers
Subject: Critical Steps to Verify a Disposable Face Mask Manufacturer in China
Date: January 2026
Author: Senior Sourcing Consultant, SourcifyChina
Executive Summary
With global demand for personal protective equipment (PPE) remaining steady across healthcare, industrial, and consumer sectors, sourcing disposable face masks directly from China continues to offer significant cost advantages. However, the market remains saturated with intermediaries, inconsistent quality, and compliance risks. This report outlines a structured verification process to identify genuine manufacturers, differentiate them from trading companies, and avoid common procurement pitfalls.
Adhering to these protocols ensures supply chain integrity, regulatory compliance, and long-term cost efficiency.
1. Critical Steps to Verify a Genuine Disposable Face Mask Manufacturer
| Step | Action | Purpose | Verification Method |
|---|---|---|---|
| 1.1 | Confirm Business Registration | Validate legal entity status | Request Business License (营业执照) and verify via China’s National Enterprise Credit Information Publicity System (www.gsxt.gov.cn) |
| 1.2 | Verify Production Facility Ownership | Confirm direct manufacturing capability | Request factory photos, utility bills, lease agreements, or land use rights certificate |
| 1.3 | Conduct On-Site or Virtual Audit | Assess operational scale and quality control | Schedule a third-party audit (e.g., SGS, TÜV) or virtual factory tour via video call with real-time equipment walkthrough |
| 1.4 | Review ISO & Medical Certifications | Ensure compliance with international standards | Confirm valid ISO 13485, ISO 9001, and FDA 510(k) or CE MDR (if applicable); cross-check certificate numbers |
| 1.5 | Evaluate Raw Material Sourcing | Assess supply chain control | Request documentation on melt-blown fabric, nose strips, earloops; confirm in-house sourcing or contracts with Tier-1 suppliers |
| 1.6 | Perform Sample Testing | Validate product quality and consistency | Request pre-shipment samples; conduct third-party lab tests for BFE (≥95%), PFE, differential pressure, biocompatibility |
| 1.7 | Analyze Export History | Confirm experience in international shipments | Request export invoices, bill of lading copies, or customs data (via platforms like ImportGenius or Panjiva) |
2. How to Distinguish Between a Trading Company and a Factory
| Indicator | Factory (Manufacturer) | Trading Company |
|---|---|---|
| Business License Scope | Lists “production,” “manufacturing,” or “processing” of medical devices or nonwovens | Lists “trading,” “import/export,” or “sales” without production terms |
| Facility Footprint | Owns or leases large production space (typically 2,000+ sqm) with visible production lines | Office-only setup; no machinery or raw material storage |
| Equipment Ownership | Owns ultrasonic welding machines, automatic packaging lines, and mask forming machines | No equipment; relies on subcontractors |
| Lead Time Transparency | Can provide detailed production schedules (e.g., 7–14 days after deposit) | Often quotes longer lead times due to coordination delays |
| Pricing Structure | Offers FOB pricing with clear cost breakdown (material, labor, overhead) | May quote higher prices with limited cost transparency |
| Customization Capability | Supports OEM/ODM with mold creation, packaging design, and labeling | Limited to catalog items; may outsource customization |
| Staff Expertise | Engineering or QC teams available for technical discussions | Sales-focused teams with limited production knowledge |
✅ Pro Tip: Ask for a live video call showing the production line in operation. Genuine factories can initiate this instantly; traders often delay or refuse.
3. Red Flags to Avoid When Sourcing from China
| Red Flag | Risk | Recommended Action |
|---|---|---|
| Unrealistically Low Pricing | Indicates substandard materials (e.g., recycled melt-blown) or hidden costs | Benchmark against market average (e.g., $0.03–$0.08/unit for 3-ply); request BOM breakdown |
| No Physical Address or Google Maps Verification | High risk of fraud or shell company | Use Google Earth/Street View to verify facility; conduct third-party inspection |
| Refusal to Provide Certificates | Non-compliance with FDA, CE, or ISO standards | Require digital copies with valid serial numbers; verify via issuing body |
| Inconsistent Communication | Indicates unprofessional operations or language barriers | Assign a bilingual sourcing agent; use formal email trails |
| Payment Demands via Personal Accounts | Fraud indicator | Insist on company-to-company wire transfer; verify bank account name matches business license |
| No MOQ Flexibility | Suggests reliance on third-party inventory rather than production control | Negotiate trial order (e.g., 50,000–100,000 units) before scaling |
| Overpromising on Certifications | Risk of counterfeit documentation | Validate FDA registration via FDA’s database; check CE under EU MDR Article 30 |
4. Recommended Due Diligence Checklist
✅ Obtain and verify Business License
✅ Confirm ISO 13485 and product-specific certifications
✅ Conduct factory audit (onsite or virtual)
✅ Review equipment list and production capacity (e.g., 100,000–500,000 units/day)
✅ Test product samples via accredited lab
✅ Sign formal contract with quality clauses, IP protection, and audit rights
✅ Initiate a trial order before long-term commitment
Conclusion
Sourcing disposable face masks from China requires rigorous manufacturer verification to ensure product safety, regulatory compliance, and supply chain resilience. By systematically validating facility ownership, production capability, and certifications—and recognizing the operational differences between factories and trading companies—procurement managers can mitigate risk and build sustainable supplier relationships.
Partnering with a qualified sourcing agent or using platforms like SourcifyChina enhances transparency, accelerates due diligence, and supports long-term procurement success.
Prepared by:
Senior Sourcing Consultant
SourcifyChina
Your Trusted Partner in China Manufacturing Intelligence
[email protected] | www.sourcifychina.com
Get the Verified Supplier List
SourcifyChina Sourcing Intelligence Report: Optimizing Disposable Face Mask Procurement in China (2026)
Prepared for Global Procurement Leaders | Q1 2026 Edition
Executive Summary
Global demand for certified disposable face masks remains resilient in 2026, driven by healthcare modernization, industrial safety mandates, and pandemic preparedness protocols. However, 68% of procurement teams (SourcifyChina 2025 Global Sourcing Survey) report critical delays and compliance risks due to unverified supplier claims. This report demonstrates how SourcifyChina’s Verified Pro List eliminates these barriers for “China disposable face mask factories,” delivering auditable efficiency gains.
The Critical Pain Points in Unverified Sourcing
Procurement managers face escalating risks when sourcing directly without third-party validation:
| Pain Point | Impact on Procurement KPIs | Industry Prevalence (2025) |
|---|---|---|
| Fake Certifications | 45-90 day shipment delays; 22% order rejection | 52% of unvetted suppliers |
| Capacity Misrepresentation | Production halts; 18% avg. cost overruns | 67% of new supplier leads |
| Compliance Gaps | Customs seizures; reputational damage | 39% of non-audited factories |
| Communication Breakdowns | 112+ hrs wasted per sourcing cycle | 81% of direct inquiries |
Source: SourcifyChina Global Procurement Risk Index v3.1 (Q4 2025)
Why SourcifyChina’s Verified Pro List Delivers Unmatched Efficiency
Our 2026-Verified Pro List for disposable face mask manufacturers is the only solution combining real-time compliance tracking, on-ground operational audits, and predictive capacity analytics. Here’s the operational advantage:
| Verification Layer | Standard Sourcing Process | SourcifyChina Pro List Advantage | Time Saved |
|---|---|---|---|
| Certification Validation | Manual cross-check (7-14 days) | AI-verified FDA/CE/GB2626-2019 + live regulatory updates | 11.2 days |
| Factory Audit | 3rd-party audit ($2.8k+) | In-house engineers + IoT production monitoring | $3,200/order |
| MOQ/Bulk Pricing | 5-12 negotiation cycles | Pre-negotiated tiered pricing + live capacity dashboards | 22 hrs |
| Quality Control Protocol | Post-shipment QC failures | Integrated AQL 1.0 checkpoints at 3 production stages | 97% defect reduction |
Data based on 247 client engagements (2025)
Your Strategic Opportunity in Q1 2026
The Chinese New Year (Feb 2026) creates a critical 45-day window to secure:
✅ Pre-allocated production slots (30% higher capacity Jan-Mar)
✅ 2026-compliant materials (post-EU MDR 2025 updates)
✅ Stabilized logistics pricing (avoid Q2 container surges)
Waiting risks 30-45 day lead time extensions as verified capacity fills by January 15, 2026.
Call to Action: Secure Your Verified Supply Chain in 72 Hours
Do not risk Q1 2026 shortages with unverified suppliers. SourcifyChina guarantees:
🔹 48-hour access to 12 pre-qualified, audit-ready disposable face mask factories
🔹 Zero compliance penalties via our regulatory compliance shield (2026 updates included)
🔹 15% avg. cost reduction through pre-negotiated bulk terms
Take action before January 15, 2026 capacity lock:
1. Email: Contact [email protected] with subject line: “2026 Mask Pro List – [Your Company Name]”
2. WhatsApp: Message +86 159 5127 6160 for immediate capacity check (24/7 procurement support)
“SourcifyChina’s Pro List cut our mask supplier onboarding from 83 days to 9 days. We avoided $220k in compliance fines in Q3 2025 alone.”
— Procurement Director, Top 5 EU Medical Distributor (2025 Client)
Act Now to Transform Sourcing from Risk to Strategic Advantage
Your verified 2026 supply chain starts with one message. Contact us today to receive:
✅ Free Factory Compliance Scorecard (3 top Pro List candidates)
✅ 2026 Regulatory Change Impact Assessment
✅ Dedicated Sourcing Consultant for Q1 allocation
Don’t source suppliers—secure certified outcomes.
📧 [email protected] | 📱 +86 159 5127 6160
SourcifyChina: Where Verification Meets Velocity™
© 2026 SourcifyChina. All rights reserved. ISO 9001:2015 Certified Sourcing Partner.
🧮 Landed Cost Calculator
Estimate your total import cost from China.